← Back to news
Y

Yahoo Finance

HELOC rates today, November 16, 2025: With another Fed rate cut in doubt, this might be as low as rates go

Y

Best high-yield savings interest rates today, November 16, 2025 (Earn up to 4.3% APY)

Y

Best CD rates today, November 16, 2025 (lock in up to 4.1% APY)

Y

Jim Cramer Considers Lam Research a “Better Company” Than Applied Materials

Y

Jim Cramer Notes Conagra’s “Flat Revenues for Multiple Years”

Y

Jim Cramer on CarMax: “I Would Not Own That Stock”

Y

Jim Cramer on ServiceNow: “If You Invest for the Long Term, I Want You to Hold It”

Y

Jim Cramer on Coterra Energy: “This Stock’s Been Very Strong for the Past Couple Weeks”

Y

Jim Cramer on Hertz: “It’s a Speculative Stock”

Y

Barclays (BCS) Upgraded to Buy as CFRA Highlights Strong Profitability and Earnings Resilience

Y

Jim Cramer on American Express: “I Think That Company’s Great”

Y

S&P Raises Schwab (SCHW) Outlook After Strong Earnings and Better Interest-Rate Risk Controls

Y

Jim Cramer Says “Even Disney Seems to Anticipate a Near-Term Soft Spot”

Y

Bank of America (BAC) Gains Price Target Upgrade as Q3 Earnings Beat Analyst Expectations

Y

Jim Cramer Highlights StubHub’s “Disappointing Result”

Y

Visa (V) Beats Q4 Revenue Estimates as Strong U.S. Consumer Spending Drives Card Transactions

Y

Jim Cramer on Live Nation Entertainment: “Another Stock That Had Been Doing Very, Very Well Until Recently”

Y

Citigroup (C) Partners With Coinbase to Expand Digital Asset Payment Solutions for Institutional Clients

Y

American Express (AXP) Upgraded to Hold After Strong Quarterly Performance and Card Launch

Y

Jim Cramer on Sweetgreen: “Not a Good Performer”

Y

UBS Reaffirms Buy Rating on JPMorgan (JPM) as AI Drives Revenue Growth and Innovation

Y

Jim Cramer on TKO: “Its Business Seems to Be on Fire”

Y

Tempus AI Retains Buy Rating as Canaccord Adjusts Price Target to $95 After Q3 Beat

Y

Guggenheim Reaffirmed Buy on GeneDx at October End, Lifted Price Target to $170 After Q3 Beat

Y

Teladoc Health Held In-Line Rating in Late Ocotber as Evercore Reversed Price Target Back to $8

Y

10x Genomics Expands Flex Lineup with High-Throughput Single-Cell Assay Launch

Y

Morgan Stanley Stays Neutral on Doximity, Highlights Strength in Video Module Business

Y

Piper Sandler Lifts Hinge Health Target to $71 After Q3 Beat and Raised Guidance

Y

Mizuho Raised Waystar Target to $50, Reaffirmed Outperform After Q3 Strength

Y

UBS Ups BrightSpring Target to $42, Reiterated Buy After Beat-and-Raise Q3

Y

Veeva Expands Basics Suite as Over 100 Biotechs Adopt Platform for Scalable Growth

Y

Morgan Stanley Lifted GE HealthCare Target to $80 in Late October, Citing Strong Orders and Backlog

Y

Erste Group Downgrades Arista Networks (ANET) Stock to Hold from Buy

Y

Citi Raises PT on Lam Research (LRCX) Stock

Y

William Blair Maintains Bullish Stance on Costco Wholesale (COST) Stock

Y

CMB International Securities Maintains Buy Rating on ServiceNow (NOW) Stock

Y

Evercore ISI Raises PT on Advanced Micro Devices (AMD) Stock

Y

Salesforce (CRM) Signs Definitive Agreement for Acquisition of Spindle AI

Y

Tigress Financial Raises PT on Mastercard (MA) Stock

Y

Bank of America Securities Maintains Buy Rating on Taiwan Semiconductor Manufacturing (TSM) Stock

Y

BofA Maintains Buy Rating on NVIDIA (NVDA) Stock

Y

Microsoft (MSFT) Expands Data Center Build-out with an AI Super Factory, Reports WSJ

Y

A slowing wartime economy pushes the Kremlin to tap consumers for revenue

Y

BNP Paribas Upgrades Comcast (CMCSA) to Neutral

Y

UBS Lifts Stanley Black & Decker (SWK) Target, Reaffirms Buy Rating

Y

Goldman Sachs Cuts Brown & Brown (BRO) Price Target, Keeps Neutral Rating

Y

Mondelez (MDLZ) Target Lowered to $62 as Analyst Maintains Neutral Stance

Y

Morgan Stanley Trims Clorox (CLX) Price Target After Soft Q1 Performance

Y

JPMorgan Lowers Costco (COST) Price Target to $1,025, Maintains Overweight Rating

Y

Bernstein Raises CNI Price Target to $109.44, Maintains Market Perform Rating

Y